Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma clinical trials

Explore recruiting aetiological treatment of moderate to severe allergic rhinitis rhinoconjunctivitis with or without mild to moderate controlled allergic asthma clinical trials.

Also recruiting in Europe

Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial to evaluate efficacy and safety of immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae and Lepidoglyphus destructor.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial to evaluate efficacy and safety of immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae and Blomia tropicalis

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial of efficacy and safety with Dermatophagoides pteronyssinus and Dermatophagoides farinae mannan-conjugated allergoids in patients with rhinitis/rhinoconjunctivitis, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae_MM09-SIT-063

Spain, Portugal

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial of efficacy and safety with Dermatophagoides pteronyssinus and Dermatophagoides farinae mannan-conjugated allergoids in patients with rhinitis/rhinoconjunctivitis, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae _MM09-SIT-069

Portugal, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma trials by city

Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Toronto Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Vancouver Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Montreal Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Calgary Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Edmonton Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Ottawa Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Winnipeg Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Quebec City Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Hamilton Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Kitchener Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in London Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Halifax Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in New York Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Los Angeles Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Chicago Aetiological Treatment Of Moderate To Severe Allergic Rhinitis Rhinoconjunctivitis With Or Without Mild To Moderate Controlled Allergic Asthma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease